The pharmaceutical industry spends nearly 11 billion dollars a year marketing their products to doctors. Reformers worry that this is eroding professionalism and ethical standards within the medical profession—and that patients can no longer trust their doctors to make decisions based on good evidence. Connecticut lawmakers are considering legislation that would ban gifts to doctors and the mining of medical data—policies that follow in the footsteps of states like Minnesota and Vermont. Meanwhile, the federal government considers requiring pharmaceutical companies to report all of their payments to doctors to a publicly accessible central, online, database. Some doctors and pharmaceutical companies argue that increased regulation makes for a hostile business environment and disregards the importance of internal ethics codes. Join the conversation about conflicts of interest in medicine—should patients know who is taking their doctors out to lunch?